Differential Clearance of Lu-PSMA-617 from Metastatic Prostate Cancer Lesions and Normal Tissues creates a Window for Safe Application of DNA Repair Inhibitors
Russell, J.; Grkovski, M.; O'Donoghue, J. A.; Franca Velo, A.; Krebs, S. S.; Bodei, L.; Schoder, H.; Humm, J. L.
Show abstract
BackgroundDNA repair inhibitors may safely enhance targeted radiotherapy if they can be administered when radioisotope has cleared from critical normal tissues. We investigated whether the kinetics of [177Lu]Lu-PSMA-617 (Pluvicto) would be consistent with such a strategy in metastatic castrate resistant prostate cancer (mCRPC). Materials and MethodsPluvicto effective t1/2 was measured for organs-at-risk (kidneys, parotid and submandibular glands) and lesions from 60 mCRPC patients. Based on this, a safe strategy for DDR inhibition was defined, and its potential benefit to the lesion was calculated, using published in vitro radiosensitivity data. ResultsPluvicto clearance is almost 3x faster in normal organs-at-risk compared to lesions. Using pre-clinical estimates of DDRi sensitization, a meaningful increase in lesion effective treatment dose could be achieved with minor additional risk to normal organs.
Matching journals
The top 1 journal accounts for 50% of the predicted probability mass.
Similar papers in this journal
- Redefining FLASH RT: the impact of mean dose rate and dose per pulse in the gastrointestinal tract 94%
- FLASH Radiotherapy Mitigates Radiation-Induced Lymphopenia and Prevents Immunosuppression via Chk1-STAT3 Axis Modulation in a Preclinical Thoracic Irradiation Model 94%
- Discordance in acute gastrointestinal toxicity between synchrotron-based proton and linac-based electron ultra-high dose rate irradiation 93%
Similar papers in this journal
- Avasopasem Manganese acts as both a Radioprotector and a Radiomitigator of Radiation-Induced Acute or Late Effects. 95%
- Leveraging intelligent optimization for automated, cardiac-sparing accelerated partial breast treatment planning 93%
- Meta-Analysis of Adenoviral p53 Gene Therapy Clinical Trials in Recurrent Head and Neck Squamous Cell Carcinoma 92%
Similar papers in this journal
- Dosimetric and biologic intercomparison between electron and proton FLASH beams 95%
- Precision association of lymphatic disease spread with radiation-associated toxicity in oropharyngeal squamous carcinomas 94%
- LITE SABR M1: a Phase I Trial of Lattice Stereotactic Body Radiotherapy for Large Tumors 93%
Similar papers in this journal
- Morphological changes after cranial fractionated photon radiotherapy: localized loss of white matter and grey matter volume with increasing dose 95%
- Detection of Alteration in Carotid Artery Volumetry Using Standard-of-care Computed Tomography Surveillance Scans Following Unilateral Radiation Therapy for Early-stage Tonsillar Squamous Cell Carcinoma Survivors: A Cross-Sectional Internally-Matched Carotid Isodose Analysis 94%
- Dose-dependent volume loss in subcortical deep grey matter structures after cranial radiotherapy 92%
Similar papers in this journal
- Small-molecule Polθ inhibitors provide safe and effective tumor radiosensitization in preclinical models 91%
- Human Papilloma Virus Circulating Cell-Free DNA Kinetics in Cervical Cancer Patients Undergoing Definitive Chemoradiation 90%
- MSCs Successfully Deliver Oncolytic Virotherapy to Diffuse Intrinsic Pontine Glioma 90%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.